| 1. |
Locatelli F,Manzoni C,Di Filippo S.The importance of convective transport[J].Kidney Int,2002,61(80):S115-S120.
|
| 2. |
Falkenhagen D,Bosch T,Brown GS,et al.A clinical study on different cellulosic dialysis membranes[J].Nephrol Dial Transplant,1987,2(6):537-545.
|
| 3. |
Woffindin C,Hoenich NA.Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes[J].Biomaterials,1988,9(1):53-57.
|
| 4. |
Streicher E,Schneider H.The development of a polysulfone membrane.A new perspective in dialysis?[J].Contrib Nephrol,1985(46):1-13.
|
| 5. |
Bowry SK,Gatti E,Vienken J.Contribution of polysulfone membranes to the success of convective dialysis therapies[J].Contrib Nephrol,2011(173):110-118.
|
| 6. |
Bowry SK.Dialysis membranes Today[J].Int J Artif Organs,2002,25(5):447-460.
|
| 7. |
Henrie M,Ford C,Andersen M,et al.In vitro assessment of dialysis membrane as an endotoxin transfer barrier:geometry,morphology,and permeability[J].Artif Organs,2008,32(9):701-710.
|
| 8. |
Yamasaki H,Nagake Y,Makino H.Determination of bisphenol A in effluents of hemodialyzers[J].Nephron,2001,88(4):376-378.
|
| 9. |
Krieter DH,Canaud B,Lemke H,et al.Bisphenol a in chronic kidney disease[J].Artif Organs,2013,37(3):283-290.
|
| 10. |
Krieter DH,Lemke HD.Polyethersulfone as a high-performance membrane[J].Contrib Nephrol,2011,173:130-136.
|
| 11. |
Abe T,Kato K,Fujioka T,et al.The blood compatibilities of blood purification membranes and other materials developed in Japan[J/OL].Int J Biomat,2011:375390.http://dx/dio.org/10.1155/2011375390.
|
| 12. |
Amore A,Bonaudo R,Ghigo D,et al.Enhanced production of nitric oxide by blood-dialysis membrane interaction[J].J Am Soc Nephrol,1995,6(4):1278-1283.
|
| 13. |
Pascual M,Schifferli JA,Pannatier JG,et al.Removal of complement factor D by adsorption on polymethylmethacrylate dialysis membranes[J].Nephrol Dial Transplant,1993,8(11):1305-1306.
|
| 14. |
Thomas M,Moriyama K,Ledebo I.AN69:evolution of the world's first high permeability membrane[J].Contrib Nephrol,2011(173):119-129.
|
| 15. |
Lavaud S,Canivet E,Wuillai A,et al.Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane[J].Nephrol Dial Transplant,2003,18(10):2097-2104.
|
| 16. |
Lavaud S,Paris B,Maheut H,et al.Assessment of the heparin-binding AN69 ST hemodialysis membrane:Ⅱ.Clinical studies without heparin administration[J].ASAIO J,2005,51(4):348-351.
|
| 17. |
Vanholder R,Baurmeister U,Brunet PA,et al.A bench to bedside view of uremic toxins[J].J Am Soc Nephrol,2008,19(5):863-870.
|
| 18. |
Haase M,Bellomo R,Morgera S,et al.High cut-off point membranes in septic acute renal failure:a systematic review[J].Int J Artif Organs,2007,30(12):1031-1041.
|
| 19. |
Gondouin B,Hutchison CA.High cut-off dialysis membranes:current uses and future potential[J].Adv Chronic Kidney Dis,2011,18(3):180-187.
|
| 20. |
Naka T,Haase M,Bellomo R."Super high-flux" or "high cut-off" hemofiltration and hemodialysis[J].Contrib Nephrol,2010(166):181-189.
|
| 21. |
Hutchison CA,Bradwell AR,Cook M,et al.Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis[J].Clin J Am Soc Nephrol,2009,4(4):745-754.
|
| 22. |
Naka T,Jones D,Baldwin I,et al.Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis:a case report[J].Crit Care,2005,9(2):R90-R95.
|
| 23. |
Nakatani T,Tsuchida K,Sugimura K,et al.Response of peripheral blood mononuclear cells in hemodialyzed patients against endotoxin and muramyldipeptide[J].Int J Mol Med,2002,10(4):469-472.
|
| 24. |
Nath KA.Renal response to repeated exposure to endotoxin:implications for acute kidney injury[J].Kidney Int,2007,71(6):477-479.
|
| 25. |
Lonnemann G.Chronic inflammation in hemodialysis:the role of contaminated dialysate[J].Blood Purif,2000,18(3):214-223.
|
| 26. |
Czermak P,Ebrahimi M,Catapano G.New generation ceramic membranes have the potential of removing endotoxins from dialysis water and dialysate[J].Int J Artif Organs,2005,28(7):694-700.
|
| 27. |
Jaber BL,Gonski JA,Cendoroglo M,et al.New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate[J].Blood Purif,1998,16(4):210-219.
|
| 28. |
Takemoto Y,Nakatani T,Sugimura K,et al.Endotoxin adsorption of various dialysis membranes:in vitro study[J].Artif Organs,2003,27(12):1134-1137.
|
| 29. |
Maitz MF,Teichmann J,Sperling CA.Surface endotoxin contamination and hemocompatibility evaluation of materials[J].J Biomed Mater Res B Appl Biomater,2009,90B(1):18-25.
|
| 30. |
Mares J,Thongboonkerd V,Tuma Z,et al.Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis[J].Kidney Int,2009,76(4):404-413.
|
| 31. |
Opatrny K Jr,Krouzzecky A,Polanská K,et al.Does an alteration of dialyzer design and geometry affect biocompatibility parameters?[J].Hemodial Int,2006,10(2):201-208.
|
| 32. |
Boudville N,Horner M,Mcewan E,et al.Effect of FX dialysers on systemic inflammation and quality of life in chronic haemodialysis patients[J].Blood Purif,2009,27(2):187-193.
|
| 33. |
Takemoto Y,Naganuma T,Yoshimura R.Biocompatibility of the dialysis membrane[J].Contrib Nephrol,2011(168):139-145.
|
| 34. |
Libetta C,Zucchi M,Gori E,et al.Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients[J].Kidney Int,2004,65(4):1473-1481.
|
| 35. |
Girndt M,Lengler S,Kaul H,et al.Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction[J].Am J Kidney Dis,2000,35(1):95-104.
|
| 36. |
Sakai K,Matsuda M.Solute removal efficiency and biocompatibility of the high-performance membrane-from engineering points of view[J].Contrib Nephrol,2011(173):11-22.
|
| 37. |
Kessler M,Gangemi C,Gutierrez Martones A,et al.Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients:a prospective proof-of-concept study[J].Hemodial Int,2013,17(2):282-293.
|
